Dr. Ashok Seth gets rare MASTER INTERVENTIONALIST Tag

  • News
  • June 15, 2017

The Award in USA makes him a cut above the rest of angioplasty experts

New Delhi/USA: He is a shy guy when it comes to flaunting laurels but this one is different and huge.

Dr. Ashok Seth, Chairman and Chief-Cardiology, Fortis-Escort heart Institute in Delhi, has become the first from Asia Pacific to be bestowed with the rare label of MASTER INTERVENTIONALIST.

He has really mastered the art of intervening in clogged arteries as his maximum number of angioplasty in one day is astronomical 16. Talking to Medicare News, he said, ‘On average I do 8-9 angioplasties daily.’ He is a tireless crusader against coronary blockage. He relates how he never gets tired and answers to the questions of patients even at the end of marathon session with calm and equanimity. He says, ‘5 years ago, I did 42 procedures in a day. Of course, this number includes angiography which takes far less time than angioplasty. I left the hospital in the wee hours next day.’ Dr. Seth further says, ‘but the biggest trophy for me is the optimum satisfaction that I see on the faces of expectant patients, which, in fact, I get daily and many a time a day.’Dr Seth, the ace interventional cardiologist (Angioplasty authority) in India could not foil the temptation of gushing about the award in USA last week that puts him at a cut above the rest of angioplasty experts in India. Thanks to his reluctance to talking about his achievements, Medicare News had hell of a hard time to snatch his bites on the rare award from the midst of his seemingly never ending bouts of navigation through clogged arteries of expectant patients.

In the video clip of the award function, Dr. Seth, straddled like a colossus of interventional cardiology while walking to the podium to collect the extraordinary accolade. The exalted designation was bestowed by the premier Society of Cardiovascular Angiography and Intervention ( USA) at a ceremony at their annual meeting in New Orleans on last week, the first from Asia Pacific in the history of the society which is the main intervention society of USA with membership across the world founded 40 years ago by Sones and Judkins ( who invented Angiography)

He was also privileged to be invited to perform a live case on the bio-resorbable stent from South Paris Massy hospital to the Euro PCR congress in Paris, the biggest intervention meeting in the world. He has performed one of the highest numbers of angiographies and angioplasties which has been duly documented in the ‘LIMCA Book of Records’.

  • Related Posts

    ‘A Knight in Shining Armor’ packed a punch in FOGSI for Gender Equality

    New Delhi: There was no fog in sight; FOGSI was shining as never before, thanks to the leadership of its outgoing president Dr Hrishikesh Pai. The over 40, 000 strong…

    • News
    • December 16, 2023
    • 39 views
    Women are on Trajectory to make Presence Felt in Healthcare India

    New Delhi: It could be advantage patients in times to come as women as workforce are increasing in healthcare domain of India. It is given that women power blended with…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Delhi HC Directs Petitioners To File Joint Written Submission On FDC Ban Issue

    Delhi HC Directs Petitioners To File Joint Written Submission On FDC Ban Issue

    Assam: 1000 Bottles of Cough Syrup Seized, One Arrested in Kharupetia

    Assam: 1000 Bottles of Cough Syrup Seized, One Arrested in Kharupetia

    Solan: DCA Under Lens As Drug Firm Didn’t Disclose Buyer Details

    Solan: DCA Under Lens As Drug Firm Didn’t Disclose Buyer Details

    DCA Forms Task Force To Investigate Smilax And Biogenetic Operations

    DCA Forms Task Force To Investigate Smilax And Biogenetic Operations

    CDSCO Constitutes Eight-Member Subcommittee To Look Into OTC Classification

    CDSCO Constitutes Eight-Member Subcommittee To Look Into OTC Classification

    Piramal Pharma open to partnerships in OTC; eyes further debt reduction

    Piramal Pharma open to partnerships in OTC; eyes further debt reduction